Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;92(6):1295-1302.
doi: 10.1016/j.jaad.2024.12.047. Epub 2025 Feb 8.

Frequency and timing of multiple skin cancer development in five cohorts

Affiliations

Frequency and timing of multiple skin cancer development in five cohorts

Lee Wheless et al. J Am Acad Dermatol. 2025 Jun.

Abstract

Background: Many patients will develop more than one skin cancer; however, most research to date has examined only case status.

Objective: Describe the frequency and timing of the treatment of multiple skin cancers in individual patients over time.

Methods: We conducted a longitudinal claims and electronic health record-based cohort study to examine the frequency of skin cancer multiplicity. We used a validated phenotype for counting individual skin cancers.

Results: Our combined cohort included 5,508,374 patients and 13,102,123 total skin cancers treated. Forty-three percent of patients treated for skin cancer were treated for more than one skin cancer, most within 2 years of the initial skin cancer. A subset of 3% of patients were treated for 10 or more skin cancers and contributed 22% of all skin cancers treated in the combined cohort.

Limitations: High-quality data on skin cancer types were not available. Databases and health records are not designed to capture skin cancer multiplicity well.

Conclusions: Nearly half of patients treated for skin cancer will develop at least one more. Better data formatting will allow for improved granularity in identifying individuals at high risk for multiple skin cancers and those unlikely to benefit from continued annual surveillance.

Keywords: cohort study; epidemiology; skin cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None disclosed.

Update of

References

    1. Rogers HW, Weinstock MA, Feldman SR & Coldiron BM Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 151, 1081–1086 (2015). - PubMed
    1. Tokez S, Hollestein L, Louwman M, Nijsten T & Wakkee M Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 156, 1300–1306 (2020). - PMC - PubMed
    1. Wehner MR Underestimation of Cutaneous Squamous Cell Carcinoma Incidence, Even in Cancer Registries. JAMA dermatology vol. 156 1290–1291 (2020). - PubMed
    1. Tokez S et al. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989–2017. JAMA Dermatol. 156, 973–981 (2020). - PMC - PubMed
    1. Marcil I & Stern RS Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch. Dermatol. 136, 1524–1530 (2000). - PubMed

MeSH terms